CMS Sacral Nerve Stimulation Coverage Policy Update (NCD 249) — What Billing Teams Need to Know

CMS has issued a modification to National Coverage Determination (NCD) 249, which governs Medicare coverage for sacral nerve stimulation (SNS) in the treatment of urinary incontinence and related conditions. This update affects urology, urogynecology, and colorectal surgery practices billing Medicare for SNS procedures—including both test stimulation and permanent implant phases. Understanding the specific coverage criteria, patient eligibility thresholds, and exclusion categories under this NCD is essential to avoiding denials and protecting revenue.

What CMS NCD 249 Covers: Sacral Nerve Stimulation for Urinary Conditions

The Centers for Medicare & Medicaid Services covers sacral nerve stimulation for three specific urinary indications under this NCD, effective January 1, 2002, with the current modification effective March 12, 2026:

1. Urinary urge incontinence
2. Urgency-frequency syndrome
3. Urinary retention

Coverage extends to both phases of SNS treatment: the temporary test stimulation phase (used to evaluate candidacy) and the permanent implantation procedure. Both are covered under this policy when all eligibility conditions are met.

SNS falls under Medicare's Prosthetic Devices benefit category—an important classification for billing teams, as it determines how claims are processed and which MAC jurisdiction rules apply.

Medicare Medical Necessity Criteria for SNS Coverage (All Three Indications)

CMS has established four conditions that must all be satisfied before Medicare will cover sacral nerve stimulation—whether for the test phase or permanent implant. These apply uniformly across urge incontinence, urgency-frequency syndrome, and urinary retention.

Criterion 1: Refractory to Conventional Therapy
The patient must have failed conventional treatment. Documentation must include evidence of prior behavioral interventions, pharmacologic management, and/or surgical corrective therapy. "Refractory" is not self-reported—it must be supported in the medical record.

Criterion 2: Appropriate Surgical Candidate
The patient must be medically fit to undergo implantation under anesthesia. Contraindications to anesthesia or surgery are disqualifying.

Criterion 3: Successful Test Stimulation (≥50% Improvement)
Before permanent implantation is covered, the patient must demonstrate a 50% or greater improvement during the test stimulation phase. CMS requires this improvement to be measured and documented through voiding diaries—not through patient self-report or clinical observation alone.

Criterion 4: Ability to Maintain Voiding Diary Records
The patient must be capable of accurately recording voiding diary data throughout the evaluation period. This is both a coverage requirement and a documentation requirement—if the patient cannot reliably complete voiding diaries, the clinical results cannot be properly evaluated, and Medicare coverage will not apply.

Who Is Excluded from CMS SNS Coverage

CMS explicitly excludes three patient categories from coverage under NCD 249, even when the primary diagnosis falls under one of the three covered indications:

• Stress urinary incontinence — SNS is not covered when the primary incontinence type is stress-related (as opposed to urge-related)
• Urinary obstruction — Mechanical or structural obstruction is excluded
• Specific neurologic diseases — This includes conditions such as diabetes with peripheral nerve involvement, where the urinary symptoms are a secondary manifestation of the neurologic disease

This last exclusion is particularly worth flagging for practices seeing diabetic patients presenting with urinary symptoms. If peripheral neuropathy is contributing to or causing the urinary condition, SNS will not meet Medicare coverage criteria regardless of how the claim is coded.

Affected Codes

This policy document does not list specific CPT or HCPCS codes. Practices should confirm applicable procedure codes (commonly used for SNS procedures such as test stimulation, lead implantation, and neurostimulator placement) with their MAC and cross-reference current CPT code descriptors independently. Claims processing instructions for NCD 249 reference the following CMS transmittals: AB-03-028, A-02-020, AB-01-166, AB-01-143, and R125CP.

Related ICD-10 Diagnosis Codes (for clinical reference — not enumerated in the NCD):

The NCD does not enumerate ICD-10-CM codes. Based on the covered indications, practices typically submit claims using codes aligned with urinary urge incontinence, urgency-frequency syndrome, and urinary retention. Verify current applicable diagnosis codes with your MAC and coding resources.

Common Denial Risks Under NCD 249

Based on the coverage criteria in this NCD, the following documentation gaps are the most common drivers of claim denials for SNS procedures:

• Missing prior treatment records. CMS requires documented evidence of behavioral, pharmacologic, or surgical treatment failure. Chart notes referencing treatment history are not sufficient if the actual treatment records aren't present.
• Voiding diary not completed or inadequate. The 50% improvement threshold is measured through voiding diaries—if the diary data is incomplete or missing, the claim lacks the clinical evidence CMS requires.
• Wrong incontinence type coded. Stress incontinence is explicitly excluded. Ensure your ICD-10 selection reflects urge incontinence or urgency-frequency syndrome, not mixed or stress incontinence.
• Neurologic comorbidities not evaluated. Diabetic patients with peripheral neuropathy presenting with urinary symptoms may be excluded. A documented evaluation ruling out peripheral nerve involvement as the causative factor should be in the chart before proceeding to SNS.

What Your Billing Team Should Do